Abstract
Background. The period after heart failure hospitalization requires coordinated reassessment of congestion, treatment tolerability and continuity of care.
Objective. To examine evidence on follow-up packages, treatment optimization, safety and patient experience, and identify boundaries for local adaptation.
Methods. Focused PubMed Title/Abstract discovery on 6 October 2026 used a relevance cap of 45 records plus targeted supplementary sources. English-language selection was purposive. Indexed records and abstracts were verified; seven lawful PMC copies supplied accessible passages. No exhaustive search, duplicate human screening, registered protocol, new meta-analysis or formal certainty grading was performed.
Synthesis. STRONG-HF demonstrated benefit from rapid medication up-titration with close monitoring in selected patients, with more overall adverse events and similar serious or fatal event rates [1]. PACT-HF, CONNECT-HF and BEAT-HF did not improve their primary clinical composites or readmission endpoints [2, 3, 4, 5]. These bundles and populations differ; cross-trial contrasts cannot identify a single effective component. TIM-HF2 supported structured remote management in selected ambulatory patients with prior-year hospitalization [6]. Observational follow-up associations were smaller when time-dependent bias was addressed [7]. Within-trial secondary analyses share parent cohorts. Patient-experience gains and clinical-event effects require separate assessment. Shared parent cohorts, differing usual-care comparators and phenotype-specific eligibility constrain synthesis. A completed appointment is a process measure, while safety, treatment response and informed participation require separate assessment.
Conclusion. Follow-up should be assessed through the clinical response it enables and its safety, feasibility and patient-centered outcomes. A proposed Saudi adaptation needs its own local evaluation; no measured Saudi effects are reported.
Keywords
- heart failure
- transitional care
- treatment optimization
- readmission
- remote monitoring
- safety
- patient experience
Declarations
- Ethics approval
- NA
- Consent to participate
- NA
- Consent for publication
- NA
- Funding
- NA
- Competing interests
- NA
- Author contributions
- NA
- Data availability
- NA
- Registration
- NA
- Acknowledgements
- NA
Comments
Commenting requires an account and sign-in.